Colin Wilde, PhD
Project title: Cancer cell models to test metabolic intervention strategies (ESR 8)
UNTIL JANUARY 2020
Chief Scientific Officer and Executive Director
AvantiCell Science Ltd
GibbsYard, Auchincruive
Ayr KA6 5HW
Scotland, UK
Web page: http://www.avanticell.com
E-mail: colin.wilde@avanticell.com
Phone: +44 (0)1292 521060
Fax: +44 (0)1292
Colin Wilde, PhD, co-founded AvantiCell Science Limited (ACS) in 2006 and serves as its Chief Scientific Officer and Executive Director. Dr. Wilde trained as a biochemist and has published more than 100 research papers in the field of biochemistry/cell biology; he is a named inventor on ten patents or patent applications in related fields. Colin leads AvantiCell’s commercial science business and oversees its programme of technical innovation in the field of cell-based analysis, which has secured >€10M in public funding support. He is also a co-founder and Executive Director of AvantiCell AsiaPacific Sdn Bhd, a Malaysian wholly-owned ACS subsidiary.